Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

31.50
Delayed Data
As of Jul 31
 +0.97 / +3.18%
Today’s Change
9.85
Today|||52-Week Range
33.74
+95.53%
Year-to-Date

Today’s Trading

Previous close30.53
Today’s open30.75
Day’s range30.65 - 31.52
Volume2,021,475
Average volume (3 months)2,109,661
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)+102.56%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio20.4
Price/Sales2.74
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
DNAIProNAi Therapeutics ...+1.78+6.95%
VBLTVascular Biogenics L...+0.02+0.33%
NEPTNeptune Technologies...0.000.00%
TEVATeva Pharmaceutical-0.05-0.07%
Data as of 4:03pm ET, 07/31/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.18
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts